Press Releases

DATE POST
June 16, 2017
Aurora BioPharma to Present at the 2017 BIO International Convention
Cambridge, MA, June 16, 2017 -- Aurora BioPharma, Inc., a clinical stage biotechnology company developing genetically reprogrammed T Cell therapy to treat Solid and Liquid tumors, announced today that company CEO and President, Robert Brooks, will present at the 2017 BIO International Convention taking place at the San Diego Convention Center June 19 – 22.
May 10, 2017
Aurora BioPharma to Attend the New York BIO 2017 Annual Conference 10 on the Park @ Time Warner Center in Columbus Circle
Cambridge, MA, May 10, 2017 -- Aurora BioPharma, Inc., a clinical stage biotechnology company developing a breakthrough in cancer treatment, announced today that company CEO and President, Robert Brooks, will attend the New York BIO 2017 Annual Conference taking place May 10-11, at 10 on the Park @ Time Warner Center in Columbus Circle. The event attracts a global audience including attendees from Europe and Asia. The conference brings together emerging and established companies, investors, business development professionals, and scientists advancing life science discoveries.
April 27, 2017
Aurora BioPharma to Attend Pioneers 2017 at the Mandarin Oriental Hotel in New York
Cambridge, MA, April 27, 2017 -- Aurora BioPharma, Inc., a clinical stage biotechnology company developing a breakthrough in cancer treatment, announced today that company CEO and President, Robert Brooks, will attend Pioneers 2017 presented by Joseph Gunnar & Co., LLC taking place Tuesday May 2nd at the Mandarin Oriental Hotel in New York.
April 8, 2017
Aurora BioPharma To Join In On A Presentation And Discussion On The GBM AGILE Trial At The Ritz-Carlton, Pentagon City
Cambridge, MA, April 8, 2017 -- Aurora BioPharma, Inc., a clinical stage biotechnology company developing a breakthrough in cancer treatment, announced today that company CEO and President, Robert Brooks, will join in on a presentation and discussion of the GBM AGILE (Adaptive, Global, Innovative, Learning Environment) trial. The meeting is being held at the Ritz Carlton, at Fashion Centre at Pentagon City, April 11th.
April 4, 2017
Aurora BioPharma to Attend the Needham & Company's 16th Annual Healthcare Conference
Cambridge, MA, April 4, 2017 -- Aurora BioPharma, Inc., a clinical stage biotechnology company developing a breakthrough in cancer treatment, announced today that company CEO and President, Robert Brooks, will attend the Needham & Company's 16th Annual Healthcare Conference taking place April 4 - 5. The two-day event attracts institutional investors, venture capitalists, and executives from leading public and private companies in Biotechnology, Specialty Pharmaceuticals, Diagnostics and Services, and Medical Technology sectors.
March 15, 2017
Aurora BioPharma to Attend the Oppenheimer & Co. 27th Annual Healthcare Conference at the Westin New York Grand Central in New York City
Cambridge, MA, March 15, 2017 -- Aurora BioPharma, Inc., a clinical stage biotechnology company developing CAR T Cell Therapy to treat Solid and Liquid tumors, announced today that company CEO and President, Robert Brooks, will attend the Oppenheimer & Co. 27th Annual Healthcare Conference on March 21-22, 2017 at The Westin New York Grand Central in New York City. The event is one of the most important investor conferences in the healthcare industry. Investors will have access to and be able to gain insight from key thought leaders from public and private companies spanning all major sectors: bio & specialty pharmaceuticals; medical devices; healthcare facilities; life science tools and diagnostics; healthcare information technology and distribution, and healthcare providers. Company executives will address topical issues such as health reform; generic drug regulation; development of new pharmaceutical and biotechnology products; product safety, patent issues and Food and Drug Administration policy.
March 14, 2017
Aurora BioPharma to Attend the Rodman & Renshaw "A Future Without Cancer" Conference on Friday, March 17, 2017
CAMBRIDGE, MA, March 14, 2017 -- Aurora BioPharma, Inc. a clinical stage biotechnology company developing CAR T Cell Therapy to treat Solid and Liquid tumors, announced today that company CEO and President, Robert Brooks, will attend "A Future Without Cancer," a Rodman & Renshaw Premier Series conconference being held on Friday, March 17, 2017.
March 13, 2017
Aurora BioPharma to Attend 29th Annual ROTH Conference at the Ritz-Carlton, Laguna Niguel in Dana Point, CA
CAMBRIDGE, MA, March 13, 2017 -- Aurora BioPharma, a clinical stage biotechnology company, developing genetically programmed CAR T Cell Therapy to treat Liquid and Solid tumors, will attend the 29th Annual ROTH Conference on March 13, 2017 at the Ritz Carlton, Laguna Niguel, in Dana Point, CA. Robert Brooks, President and CEO, will be available for one-on-one meetings.
January 8, 2017
Aurora BioPharma Attends the 2017 J.P. Morgan Healthcare Conference
CAMBRIDGE, MA, January 8, 2017 -- Aurora BioPharma, Inc. attends the 35th Annual J.P. Morgan Healthcare Conference taking place January 9-12, 2017 at the Westin St. Francis Hotel in San Francisco, California.
Sept 26, 2016
Aurora BioPharma to Attend Ladenburg Thalmann’s Healthcare Conference
CAMBRIDGE, MA,September 26, 2016 -- Aurora BioPharma, Inc. will attend Ladenburg Thalmann's 2016 Healthcare Conference Tuesday, September 27th at the Sofitel New York hotel. The day event will feature corporate presentations and pre-scheduled meetings.
Sept 15, 2016
Aurora BioPharma CEO to Present at the Aegis Capital Corp. 2016 Growth Investment Conference
CAMBRIDGE, MA, September 15, 2016 -- Aurora BioPharma, Inc., CEO, Robert Brooks, will present at the Aegis Capital Corp. 2016 Growth Investment Conference taking place at the Encore at Wynn Las Vegas September 20-22.
Sept 13, 2016
Aurora BioPharma CEO to Present at the 15TH Annual BIO Investor Forum
CAMBRIDGE, MA, September 13, 2016 -- Aurora BioPharma, Inc. is pleased to announce that our CEO, Robert Brooks, will present at the 15th Annual BIO Investor Forum, a gathering attracting more than 900 private equity and public investors, research analysts, and industry executives participating in some 1,700 meetings and 175 public and venture stage company presentations. The event will take place October 18- 19 at the Westin St. Francis Hotel in San Francisco.
Sept 9, 2016
Aurora BioPharma to Attend the 5TH Annual OctoberINVESTfest Conference at the World Trade Center 7
CAMBRIDGE, MA, September 9, 2016 -- The CEO of Aurora BioPharma, Robert Brooks, will attend OktoberINVESTfest, the 5th Annual Investors Conference to be held once again at The New York Academy of Sciences, World Trade Center 7, on September 28, 2016. The building is one of New York's LEED- certified green buildings, representative of Bavaria's Energy Turn Around initiatives. This year's program will feature distinguished panelists and speakers complimented by power networking at the "Unconference Luncheon".
Sept 7, 2016
Aurora BioPharma to Attend the Rodman & Renshaw 18th Annual Global Investment Conference at the New York Palace Hotel
CAMBRIDGE, MA, September 7, 2016 -- The CEO of Aurora BioPharma, Inc., Robert Brooks, will attend the Rodman & Renshaw 18th Annual Global Investment Conference being held at the New York Palace Hotel in New York City on September 11 - 13, 2016. The conference is expected to attract an audience of 2,000 attendees from the financial, investment and corporate arenas. Keynote Speakers are The Right Honourable Sir John Major KG CH, former Prime Minister of the United Kingdom and Jeb Bush, 43rd Governor of Florida.
Sept 7, 2016
Aurora BioPharma to Attend the 23rd Annual NewsMakers in the Biotech Industry Conference
CAMBRIDGE, MA, September 7, 2016 -- The CEO of Aurora BioPharma, Inc., Robert Brooks, will attend the 23rd annual NewsMakers in the Biotech Industry Conference to be held at the Millennium Broadway Hotel and Conference Center in New York, September 9th, 2016.
May 27, 2016
Aurora BioPharma to present at the Fifth Annual Marcum Microcap Conference
CAMBRIDGE, MA - May 27, 2016 - Aurora BioPharma, a company commercializing cutting-edge cancer adoptive cell immunotherapy, with CAR T cells in liquid and solid tumors, announced today its CEO, Robert Brooks, will attend the 5th Annual Marcum MicroCap Conference on June 1-2, 2016 in New York City at the Grand Hyatt Hotel.
May 26, 2016
Aurora BioPharma to Present at the 2016 BIO International Convention
CAMBRIDGE, MA -May 26, 2016- Aurora BioPharma announced that its CEO, Robert Brooks, will be presenting at the 2016 BIO International Convention taking place June 6-9, 2016 at the Moscone Center in San Francisco, California.
April 30, 2016
Aurora BioPharma CEO Joins Dignitaries During AANS Annual Scientific Meeting in Chicago
CAMBRIDGE, MA -May 26, 2016- Aurora BioPharma announced that its CEO, Robert Brooks, will be presenting at the 2016 BIO International Convention taking place June 6-9, 2016 at the Moscone Center in San Francisco, California.
April 4, 2016
Aurora BioPharma CEO to Present Cutting-Edge Cancer Fighting Technology at BIO-Europe Spring in Stockholm, Sweden
CAMBRIDGE, MA - April 4, 2016 - The CEO of Aurora BioPharma, Inc., Robert Brooks, will present the newest technology based on cutting-edge immunotherapy to kill cancer, at the tenth annual BIO-Europe Spring international life science partnering conference to be held in Stockholm, Sweden, April 4 - 6, 2016. Organized by EBD Group, the event is a world class gathering attracting over 2,000 life science executives. It is co-hosted by Stockholm Business Region and Stockholm Science City Foundation.
April 1, 2016
The CEO of Aurora BioPharma is a Featured Guest on CBS in a Discussion on Cancer Research in Pediatrics
CAMBRIDGE, MA - April 1, 2016 - Aurora BioPharma, Inc. CEO, Robert Brooks, is joined by Raymond Rodriguez-Torres, Chairman of the “Live Like Bella” Childhood Cancer Foundation on the set of CBS Miami public affairs show “Focus On South Florida”, hosted by Rudabeh Shahbazi. The panelists discussed the newest research aimed at finding a cure for pediatric cancer. Organizers urged Congress to enact the “Bella Bill” – legislation focusing on cancer research in pediatrics – following resolutions passed by City of Miami and Miami-Dade County commissioners in support of the bill.
April 1, 2016
CBS Miami Focus on South Florida Pediatric Cancer:
http://miami.cbslocal.com/2016/04/03/focus-on-south-florida-pediatric-cancer-research/
February 9, 2016
Medcity News: Aurora Biopharma tackling glioblastoma with CAR-T immunotherapy
http://medcitynews.com/2016/02/aurora-glioblastoma-immunotherapy/
January 26, 2016
Aurora BioPharma, Inc. To Present CAR T Cell Therapy Clinical Data In Solid Tumors at BIO CEO and Investor
CAMBRIDGE, MA – January 26, 2016 – Aurora BioPharma, Inc. CEO, Robert Brooks, will present promising CAR T Cell Therapy data in Solid Tumor from FDA Phase I Clinical trials in Glioblastoma and Sarcoma at the 18th Annual BIO CEO & Investor Conference taking place February 8-9, 2016 at The Waldorf Astoria New York.
Januray 15, 2016
Aurora BioPharma, Inc. to Present Groundbreaking CAR T Therapy Clinical Data in Solid Tumors at NobleCon12 - Noble Financial Capital Markets' 12th Annual Investor Conference
CAMBRIDGE, MA – January 15, 2016 – Aurora BioPharma, Inc., based in Cambridge, Massachusetts, is a private biotechnology company commercializing cutting-edge CAR T cells and therapeutic vaccines combined with checkpoint inhibitors. The Company’s CEO, Robert Brooks, will present its clinical trial data at Club Med in Sandpiper Bay, Florida, on Tuesday, January 19, 2016 at 1:30 pm in Room 3.
January 4, 2016
Aurora BioPharma, Inc. to Attend J.P. Morgan Healthcare Conference, and Present at OneMedForum and Biotech Showcase
CAMBRIDGE, MA - January 4, 2016 - Aurora BioPharma, Inc. announces its CEO, Robert Brooks, will attend the 34th Annual J.P. Morgan Healthcare Conference, and present at the following events in San Francisco:
December 15, 2015
Aurora BioPharma, Inc. to Present at Biotech Showcase™ during JP Morgan Healthcare Conference
CAMBRIDGE, MA - December 15, 2015 - Aurora BioPharma, Inc., a private immuno-oncology company developing CAR T therapy, vaccines, and checkpoint inhibitors for solid tumors, announces it will present at the Biotech Showcase™ Annual Conference to be held in San Francisco on January 11-13, 2016.
December 15, 2015
Aurora BioPharma, Inc. to Present at the Landmark Venture Forum at the Palm Beach Marriott Resort & Spa – Singer Island
CAMBRIDGE, MA - December 15, 2015 - Aurora BioPharma, Inc., a private immune-oncology company developing CAR T therapy, checkpoint inhibitors for solid tumors, announces its CEO, Robert Brooks, will present at the Landmark Venture Forum at the Palm Beach Marriott Resort & Spa – Singer Island on December 15, 2015. This investor, by-invitation only, event will feature presentations from select companies seeking investments.
December 9, 2015
Aurora BioPharma, Inc. CEO Meets With Investors at 2015 New England Venture Summit
CAMBRIDGE, MA - December 9, 2015 - The CEO of Aurora BioPharma, Inc., Robert Brooks, will attend the New England Venture Summit taking place December 9th, 2015 at the Hilton Boston Dedham. The illustrious industry gathering is presented by youngStartup Ventures and connects top tier VCs, corporate VCs, venture capitalists, angel investors, university researchers, and incubators.
December 1, 2015
Aurora BioPharma, Inc. CEO Meets with Investors at The Family Office Super Summit
CAMBRIDGE, MA - December 1, 2015 - Aurora BioPharma, Inc. announces its CEO, Robert Brooks, will attend The Family Office Super Summit taking place December 1 - 2, 2015 at the JW Marriott Hotel on Brickell Avenue in Miami, Florida. Attendees will join hundreds of private wealth managers, family office executives, and dealmakers for the two-day gathering featuring over 60 speakers. The day is devoted to $1B+ family offices, dozens of single family offices, and hundreds of delegates.
October 12, 2015
Aurora BioPharma, Inc. to Present at OktoberINVESTfest 2015
CAMBRIDGE, MA - October 12, 2015 - Aurora BioPharma, Inc. announces its CEO, Robert Brooks, will present at OktoberINVESTfest 2015, the 4th Bavarian American Annual Investors Conference at the New York Academy of Sciences, New York City, Room 2, 2:50 - 3:15 pm EST, on October 13, 2015.
September 24, 2015
Aurora BioPharma To Present Promising CAR T Cell Therapy Clinical Data in Glioblastoma at BIO Investor Forum
CAMBRIDGE, MA - September 24, 2015 - Aurora BioPharma, Inc. announces its CEO, Robert Brooks, will present promising CAR T Cell Therapy clinical data in Glioblastoma at the BIO Investor Forum taking place at the Parc 55 Hilton Hotel in San Francisco on October 20-21, 2015.
September 16, 2015
Aurora BioPharma, Inc. Attends RESI Boston 2015
CAMBRIDGE, MA - September 16, 2015 - Aurora BioPharma, Inc. announces its participation at the Redefining Early Stage Investments (RESI) Boston 2015 conference. The event will be held at The Westin Copley Place in Boston, MA, on September 16, 2015. Life Science Nation (LSN) will be hosting the gathering in collaboration with Johnson & Johnson Innovation, JLABS (JLABS). The RESI conference attracts Corporate Venture Capital Funds, Family Offices, Venture Philanthropy Funds, VCs, and Angel groups. The event serves as an opportunity for fundraising executives to identify and meet life science investors. The goal is to develop new medical breakthroughs in the discovery of advanced technologies and cancer immunotherapies.
September 7, 2015
Aurora BioPharma, Inc. CEO to Attend the Rodman & Renshaw 2015 Annual Global Investment Conference
CAMBRIDGE, MA - September 7, 2015 - Aurora BioPharma, Inc. announces that its Chief Executive Officer, Robert Brooks, will attend the Rodman & Renshaw 17th Annual Global Investment Conference taking place at the St. Regis Hotel in New York City on September 8 - 10.
August 24, 2015
Aurora BioPharma, Inc. CEO Attends The Annual ImVacS
CAMBRIDGE, MA - August 24, 2015 - Aurora BioPharma, Inc. announces that its Chief Executive Officer, Robert Brooks, will attend the 10th Annual ImVacS: Immunotherapy and Vaccine Summit on August 24 - 28, 2015 in Boston, Massachusetts presented by the Cambridge Healthtech Institute. The event attracts over 300 international delegates from biotech and pharma every year. This year's gathering will cover vaccine, immunotherapy technologies, immunomodulatory therapeutic antibodies for cancer, combination cancer immunotherapy and others. ImVacS 2015 promises to be a prominent gathering for academic and healthcare professionals in the advancement of immunotherapies and vaccines through innovation.